Burlington teen meets donor for kidney transplant; ‘Life is too beautiful to give up on'
BURLINGTON, N.C. (WGHP) – We have a great update about a young man many of you have followed throughout the years. Albert Jeffries, known as Alj, is from Burlington and received a heart transplant nearly 10 years ago.
Now, he needs a kidney transplant. He has a donor and his surgery is scheduled for Feb. 4.
As a baby, he was diagnosed with a heart condition. Then he had his life-saving heart transplant at 13. At the age of 22, he found out that his kidneys weren't working and that he would need a new one.
NASCAR legend makes 1 millionth Give a Kid a Coat donation
His mom has been by his side for all of this. On Wednesday, she arranged an unforgettable surprise for Alj to meet the donor who is saving his life.
'I could not let go. I didn't want to let go at all,' Alj said about the moment he met his donor.
The two shared a powerful hug that held tight to hope.
'It's amazing. I really don't have the words. It was just very surreal and emotional but it was almost like we've known each other too. It was an immediate connection,' said Mandy Harris, the donor.
Two strangers, connected, at first through social media.
'I followed his story on Facebook when he was younger and had his heart transplant and then I didn't follow him for a little while and then it popped up on my Facebook page that his mom said he needed a kidney transplant,' Harris said.
Soon, they will be physically connected too.
'When I saw the post and it had the clinic information on there on how to go and get tested, I immediately just felt led to do it. I just feel at peace and I have felt at peace from the very beginning,' Harris said.
Mandy shares a part of her life to give Alj a second chance at his.
'It makes me think of her as an angel, as a guardian angel,' Alj said.
He knew the kidney was on the way, but he had no idea where it was coming from.
'I am still trying to process everything really. I didn't expect it to happen,' Alj said.
He thought he was just going to the hospital for an appointment on Wednesday but instead, his mom and the donor planned a surprise.
While in the waiting room, he got a box with a note inside that told him his donor was in the room with him. Mandy also gave him a matching sweatshirt that she was wearing to show they are a perfect match.
'It was a surprise. It was a surprise. I was like, 'Oh my god, I can't believe this is about to happen,'' Alj said.
Another surgery, another transplant and another unknown road ahead. But Alj is ready to take this journey with Mandy by his side.
'The fact that she is willing to give me a kidney, a part of herself, for me to live longer makes me appreciate her a lot. Life is too beautiful to give up on,' Alj said.
After years of following Alj's story online, the post today on Alj's Facebook page on Wednesday is about Mandy and her selfless donation.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Wellness Wednesday: ‘Teddy Bears to the Rescue'
LANSING, Mich. (WLNS) – Cooper Hospital held its annual 'Teddy Bears to the Rescue' event, where teddy bears become the patients and kindergarten students work with medical staff to diagnose and treat them. 'This helps to increase their familiarity to get comfortable with who they might be seeing in the event they ever have to come back. We help to ease their anxiety around coming to the hospital,' Max Kursh with Cooper Hospital explained. Along with prevention lessons, like swimming safety, the students also learned about staying healthy and away from the hospital. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
22 minutes ago
- Yahoo
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management team will present and participate in the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11th at 10:00 am ET. A live webcast of the presentation can be accessed through the Investors section of the Company's website at Following the live presentation, a replay of the webcast will be available on the Company's website following the presentation date. About Lyell Immunopharma, Inc. Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors. To realize the potential of cell therapy for cancer, Lyell utilizes a suite of technologies to endow CAR T cells with attributes needed to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical responses, including the ability to resist exhaustion, maintain qualities of durable stemness and function in the hostile tumor microenvironment. To learn more, please visit Contact: Ellen RoseSenior Vice President, Communications and Investor Relationserose@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
BridgeBio Pharma, Inc. (BBIO) Price Target Raised to $56 from $53 at H.C. Wainwright
BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the 13 Biotech Stocks with Huge Upside Potential. In a recent report, Raghuram Selvaraju, an expert at H.C. Wainwright, raised the price target for BridgeBio Pharma, Inc. (NASDAQ:BBIO) from $53 to $56 and kept the stock's buy rating. A team of scientists in white lab coats reviewing lab results in a research facility. Positive momentum for the company is proven by the fast uptake of the Attruby product, which is the driving force behind this bullish forecast. For adult patients with ATTR-CM, Attruby is the only nearly full (≥90%) stabilizer of Transthyretin (TTR) that has been approved in the United States to lower cardiovascular mortality and hospitalizations linked to cardiovascular disease. In general, Attruby was highly received. Abdominal pain and diarrhea were the most frequent, moderate side effects that went away without stopping the medication. BridgeBio Pharma, Inc. (NASDAQ:BBIO) provides a wide range of initiatives to facilitate patients' access to our medications. BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a novel biopharmaceutical business that was established to find, develop, test, and distribute revolutionary medications to treat people with hereditary disorders. The development programs in its pipeline span from early science to advanced clinical trials. BBIO is among the stocks with the biggest upside. While we acknowledge the potential of BBIO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data